1. Schwartsmann G, Winograd B, Pinedo HM. The main steps in the development of anticancer agents. Radiother Oncol 1988;12:301–13.
2. Johnson RK. Screening methods in antineoplastic drug discovery. J Natl Cancer Inst 1990;82:1083–4.
3. Kopka ML, Yoon C, Goodsell D, Pjura P, Dickerson RE. The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc Natl Acad Sci 1985;82: 1376–80.
4. Aristoff PA, Warpehoski MA, Kelly RC, Mitchell MA, Krueger WC, McGovern JP, Li LH. Utilization of mechanism of action and structure — activity information in the rational design of highly efficacious CC-1065 analogs. Abstract 062. Sixth NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, March 7–10, 1989.
5. Beijnen JH. Report on the Formulation of U-80,244. New Drug Development Office-European Organization of Research and Treatment of Cancer (NDDO-EORTC), Amsterdam, 1990.